End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.4 SEK | +0.39% | -0.77% | +53.89% |
06-12 | EQL Pharma Receives Approval for Listing to Nasdaq Stockholm Main Market | MT |
05-15 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.89% | 142M | |
-36.96% | 10.04B | |
-18.40% | 7.21B | |
-13.88% | 5.59B | |
-12.49% | 4.88B | |
-3.21% | 4.57B | |
+68.00% | 4.4B | |
-4.97% | 4B | |
-30.40% | 2.72B | |
-19.16% | 2.63B |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024